Target essentiality and centrality characterize drug side effects
about
Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory scienceThe use of functional chemical-protein associations to identify multi-pathway renoprotectantsNeighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapiesSystematic analysis of gene properties influencing organ system phenotypes in mammalian perturbations.Integrative analysis of ocular complications in atherosclerosis unveils pathway convergence and crosstalk.Network-Oriented Approaches to Anticancer Drug Response.Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach.Systematic Analyses and Prediction of Human Drug Side Effect Associated Proteins from the Perspective of Protein Evolution.Structural and Functional View of Polypharmacology.Utility of network integrity methods in therapeutic target identification.Viral proteins that bridge unconnected proteins and components in the human PPI network.Elucidating the genotype-phenotype relationships and network perturbations of human shared and specific disease genes from an evolutionary perspective.The Role of the Skin and Gut Microbiome in Psoriatic Disease.Systematic interrogation of diverse Omic data reveals interpretable, robust, and generalizable transcriptomic features of clinically successful therapeutic targets.Module-detection approaches for the integration of multilevel omics data highlight the comprehensive response of Aspergillus fumigatus to caspofungin
P2860
Q26778374-DD6D1800-D1C3-4250-9E3E-7BA3971C6984Q28538871-873E1F48-48E3-4792-8815-5A89C341BB60Q33767131-2C6B41D4-5841-4233-BE00-2825825241D8Q36171779-E6B67FFF-0EB0-4C66-899D-BBB356A6FAF0Q39155136-56F88269-0726-4B26-B965-2991570B35A4Q39221886-EBA2D810-126B-4B11-9A06-F5C4DEE94F67Q40786545-06E75D75-29E0-4046-8613-D926512CF2B1Q40950164-C69B4FA5-EBAA-4C1C-AB9C-A3F6E79B4390Q41580357-C39C1840-BFBD-43BA-B391-9C6BC1022B1BQ41829537-69278053-259C-4D7A-8A8A-C6B738ED971EQ42208218-F9787194-11C5-4ECF-B313-4F24EE16111DQ42986908-47FC801B-B2B1-4D65-A403-7AA07BFD2CBCQ46383713-04A4341B-F63E-4DC2-B441-6F1F4B956CBAQ55155058-5D041B36-DF03-4CCF-9A3A-E1618889B1D6Q57807574-21BD88E9-D8BF-4674-88E1-E6CC4D1DCEE0
P2860
Target essentiality and centrality characterize drug side effects
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Target essentiality and centrality characterize drug side effects
@ast
Target essentiality and centrality characterize drug side effects
@en
Target essentiality and centrality characterize drug side effects
@nl
type
label
Target essentiality and centrality characterize drug side effects
@ast
Target essentiality and centrality characterize drug side effects
@en
Target essentiality and centrality characterize drug side effects
@nl
prefLabel
Target essentiality and centrality characterize drug side effects
@ast
Target essentiality and centrality characterize drug side effects
@en
Target essentiality and centrality characterize drug side effects
@nl
P2093
P2860
P1476
Target essentiality and centrality characterize drug side effects
@en
P2093
Bram Thijssen
Haiyuan Yu
Xiujuan Wang
P2860
P304
P356
10.1371/JOURNAL.PCBI.1003119
P407
P577
2013-01-01T00:00:00Z